Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.640
+0.075 (2.92%)
Aug 8, 2025, 5:35 PM CET
Accolade Market Cap
Oryzon Genomics has a market cap or net worth of €204.63 million as of August 8, 2025. Its market cap has increased by 74.61% in one year.
Market Cap
204.63M
Enterprise Value
191.64M
Revenue
7.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.64
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 204.63M, an increase of 67.73%. That is a compound annual growth rate of 5.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 204.63M | 125.88% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | 210.12M | 66.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.91B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.21B |
| Pharma Mar | 1.39B |
| Faes Farma | 1.31B |
| Clínica Baviera | 714.61M |
| Laboratorio Reig Jofre | 240.89M |
| Atrys Health | 212.57M |